Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016753:Interleukin-10 / Q000235:genetics*; D007376:Interleukin-2 / Q000235:genetics*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000235:genetics* / Q000276:immunology; D051379:Mice; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D012263:Ribonucleosides / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology*; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; D016753:Interleukin-10; D007376:Interleukin-2; D009173:Mycophenolic Acid; D012263:Ribonucleosides; D016559:Tacrolimus; C010052:mizoribine; C046943:brequinar; D011798:Quinaldines